Clinical practice guidance for juvenile dermatomyositis (JDM) 2018-Update

Mod Rheumatol. 2020 May;30(3):411-423. doi: 10.1080/14397595.2020.1718866. Epub 2020 Feb 3.

Abstract

Juvenile dermatomyositis is the most common type of juvenile idiopathic inflammatory myopathy mainly affecting the skin and proximal muscles. We have published the Japanese version of 'Clinical practice guidance for juvenile dermatomyositis (JDM) 2018 'consisting of a review of articles in the field and evidence-informed consensus-based experts' opinion on the treatment strategy in collaboration with The Pediatric Rheumatology Association of Japan and The Japan College of Rheumatology under the financial support by 'Research on rare and intractable diseases, Health and Labor Sciences Research Grants'. This article is a digest version of the Japanese guidance.

Keywords: Diagnosis; interstitial lung disease; management; myositis-specific autoantibodies; pathophysiology.

Publication types

  • Review

MeSH terms

  • Adolescent
  • Child
  • Consensus
  • Dermatomyositis / diagnosis*
  • Dermatomyositis / drug therapy
  • Humans
  • Japan
  • Practice Guidelines as Topic*
  • Rheumatology / organization & administration
  • Societies, Medical / standards